Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer.

Cancer prevention research (Philadelphia, Pa.)(2022)

引用 2|浏览14
暂无评分
摘要
Our results show that everolimus delays mammary tumor formation in multiple mouse models, suggesting that mTOR inhibitors will be useful for the prevention of ER-negative and triple-negative breast cancer in humans. See related Spotlight, p. 787.
更多
查看译文
关键词
mtor pathway,cancer,er-negative
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要